Safety and Efficacy of Combined Resveratrol and Sirolimus in Lymphangioleiomyomatosis-Reference-Cited by-同舟云学术

Safety and Efficacy of Combined Resveratrol and Sirolimus in Lymphangioleiomyomatosis

Published:2023-05 Issue:5 Volume:163 Page:1144-1155
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Gupta Nishant,Zhang Bin,Zhou Yuan,McCormack Francis X.,Ingledue Rebecca,Robbins Nathan,Kopras Elizabeth J.,McMahan Susan,Singla Abhishek,Swigris Jeffrey,Cole Adam G.,Holz Marina K.

Funder

National Heart, Lung, and Blood Institute

National Institutes of Health

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference29 articles.

1. Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management;McCarthy;Lancet Respir Med,2021

2. Serum vascular endothelial growth factor C as a marker of therapeutic response to sirolimus in lymphangioleiomyomatosis;Gupta;Ann Am Thorac Soc,2021

3. Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial;Young;Lancet Respir Med,2013

4. Diagnostic potential of serum VEGF-D for lymphangioleiomyomatosis;Young;N Engl J Med,2008

5. Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases;Young;Chest,2010

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of the natural compound naringenin in AMPK-mitochondria modulation and colorectal cancer inhibition;Phytomedicine;2024-08

2. The role of mTORC1/TFEB axis mediated lysosomal biogenesis and autophagy impairment in fluoride neurotoxicity and the intervention effects of resveratrol;Journal of Hazardous Materials;2024-04

3. Resveratrol for the Management of Human Health: How Far Have We Come? A Systematic Review of Resveratrol Clinical Trials to Highlight Gaps and Opportunities;International Journal of Molecular Sciences;2024-01-06

4. Maladies kystiques pulmonaires de l’adulte d’origine génétique;Revue des Maladies Respiratoires;2024-01

5. A case report of lymphangioleiomyomatosis with retroperitoneal masses in pregnancy;Frontiers in Medicine;2023-12-22